Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alloonc

Alloonc?uq=PEM9b6PF
2013 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Operator of a biotechnology company intended to develop cellular therapeutic invention to cure cancer. The company's product, Mesenkiller uses a molecule which targets cancer cells that is linked with a radioactive particle killing both targeted and the surrounding non targeted cells, enabling cancer patients with efficient and effective therapeutic without having any systemic affects on the body.

Website
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1396 Milano Drive Unit 3
  • West Sacramento, CA 95691
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alloonc’s full profile, request a free trial.

Alloonc Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Mar-2018 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Alloonc Executive Team (1)

Name Title Board
Seat
Contact
Info
Astra Chang Ph.D Founder